Tactile Systems Technology Inc TCMD

NAS: TCMD | ISIN: US87357P1003 16:16

13,85 USD (+0,84%)

(+0,84%) 16:16

Grafiek Tactile Systems Technology Inc

Grafiek Tactile Systems Technology Inc

1 dag1d 0,84%
1 week1w 0,11%
1 maand1m -5,49%
3 maanden3m -2,50%
6 maanden6m 9,53%
1 jaar1j -35,63%
5 jaar5j -72,09%

Tactile Systems Technology Inc in het nieuws

Toon enkel gratis nieuws

4 juni 2022 · Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600 · Persbericht

14 mei 2022 · TACTILE SYSTEMS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tactile Systems Technology, Inc. - TCMD · Persbericht

13 april 2022 · Avation Medical Announces Appointment of Chief Marketing Officer to Executive Leadership Team · Persbericht

8 mei 2021 · TACTILE SYSTEMS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tactile Systems Technology, Inc. - TCMD · Persbericht

15 maart 2021 · Tactile Medical Appoints Kristie Burns as Senior Vice President of Marketing & Clinical Affairs · Persbericht

13 maart 2021 · TACTILE SYSTEMS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tactile Systems Technology, Inc. - TCMD · Persbericht

8 februari 2021 · Tactile Medical to Release Fourth Quarter and Fiscal Year 2020 Financial Results on February 23, 2021 · Persbericht

5 januari 2021 · Tactile Medical Announces Additions to Board of Directors · Persbericht

5 januari 2021 · Tactile Medical to Present at the ICR Conference 2021 · Persbericht

Profiel Tactile Systems Technology Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.tactilemedical.com

Hoofdzetel: Minneapolis, Minnesota Verenigde Staten

CEO: Gerald Mattys

Werknemers: 871

Aandelen Tactile Systems Technology Inc

Beurswaarde: 326,25 miljoen USD

Effecten: 23,76 miljoen

Winst per aandeel (12 maand): PLUS

Koers-winstverhouding: PLUS

Beta: 1,38

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe